The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pathak, M. K.
Right arrow Articles by Yi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pathak, M. K.
Right arrow Articles by Yi, T.
The Journal of Immunology, 2001, 167: 3391-3397.
Copyright © 2001 by The American Association of Immunologists

Sodium Stibogluconate Is a Potent Inhibitor of Protein Tyrosine Phosphatases and Augments Cytokine Responses in Hemopoietic Cell Lines1

Manas K. Pathak and Taolin Yi2

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195

Using in vitro protein tyrosine phosphatase (PTPase) assays, we found that sodium stibogluconate, a drug used in treatment of leishmaniasis, is a potent inhibitor of PTPases Src homology PTPase1 (SHP-1), SHP-2, and PTP1B but not the dual-specificity phosphatase mitogen-activated protein kinase phosphatase 1. Sodium stibogluconate inhibited 99% of SHP-1 activity at 10 µg/ml, a therapeutic concentration of the drug for leishmaniasis. Similar degrees of inhibition of SHP-2 and PTP1B required 100 µg/ml sodium stibogluconate, demonstrating differential sensitivities of PTPases to the inhibitor. The drug appeared to target the SHP-1 domain because it showed similar in vitro inhibition of SHP-1 and a mutant protein containing the SHP-1 PTPase domain alone. Moreover, it forms a stable complex with the PTPase: in vitro inhibition of SHP-1 by the drug was not removed by a washing process effective in relieving the inhibition of SHP-1 by the reversible inhibitor suramin. The inhibition of cellular PTPases by the drug was suggested by its rapid induction of tyrosine phosphorylation of cellular proteins in Baf3 cells and its augmentation of IL-3-induced Janus family kinase 2/Stat5 tyrosine phosphorylation and proliferation of Baf3 cells. The augmentation of the opposite effects of GM-CSF and IFN-{alpha} on TF-1 cell growth by the drug indicated its broad activities in the signaling of various cytokines. These data represent the first evidence that sodium stibogluconate inhibits PTPases and augments cytokine responses. Our results provide novel insights into the pharmacological effects of the drug and suggest potential new therapeutic applications.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
W. J. Janssen, K. A. McPhillips, M. G. Dickinson, D. J. Linderman, K. Morimoto, Y. Q. Xiao, K. M. Oldham, R. W. Vandivier, P. M. Henson, and S. J. Gardai
Surfactant Proteins A and D Suppress Alveolar Macrophage Phagocytosis via Interaction with SIRP{alpha}
Am. J. Respir. Crit. Care Med., July 15, 2008; 178(2): 158 - 167.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. U. A. Mollah, S. Pai, C. Moore, B. J. O'Sullivan, M. J. Harrison, J. Peng, K. Phillips, J. B. Prins, J. Cardinal, and R. Thomas
Abnormal NF-{kappa}B Function Characterizes Human Type 1 Diabetes Dendritic Cells and Monocytes
J. Immunol., March 1, 2008; 180(5): 3166 - 3175.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. El Fadili, M. Imbeault, N. Messier, G. Roy, B. Gourbal, M. Bergeron, M. J. Tremblay, D. Legare, and M. Ouellette
Modulation of Gene Expression in Human Macrophages Treated with the Anti-Leishmania Pentavalent Antimonial Drug Sodium Stibogluconate
Antimicrob. Agents Chemother., February 1, 2008; 52(2): 526 - 533.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
Ashutosh, S. Sundar, and N. Goyal
Molecular mechanisms of antimony resistance in Leishmania
J. Med. Microbiol., February 1, 2007; 56(2): 143 - 153.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
E. Y. Tan, C. L. Richard, H. Zhang, D. W. Hoskin, and J. Blay
Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway
Am J Physiol Cell Physiol, September 1, 2006; 291(3): C433 - C444.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Noren-Muller, I. Reis-Correa Jr, H. Prinz, C. Rosenbaum, K. Saxena, H. J. Schwalbe, D. Vestweber, G. Cagna, S. Schunk, O. Schwarz, et al.
From the Cover: Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis
PNAS, July 11, 2006; 103(28): 10606 - 10611.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
J. Mookerjee Basu, A. Mookerjee, P. Sen, S. Bhaumik, P. Sen, S. Banerjee, K. Naskar, S. K. Choudhuri, B. Saha, S. Raha, et al.
Sodium Antimony Gluconate Induces Generation of Reactive Oxygen Species and Nitric Oxide via Phosphoinositide 3-Kinase and Mitogen-Activated Protein Kinase Activation in Leishmania donovani-Infected Macrophages.
Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1788 - 1797.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Fan, M. Zhou, M. K. Pathak, D. J. Lindner, C. Z. Altuntas, V. K. Tuohy, E. C. Borden, and T. Yi
Sodium Stibogluconate Interacts with IL-2 in Anti-Renca Tumor Action via a T Cell-Dependent Mechanism in Connection with Induction of Tumor-Infiltrating Macrophages
J. Immunol., November 15, 2005; 175(10): 7003 - 7008.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
F. Krotz, B. Engelbrecht, M. A. Buerkle, F. Bassermann, H. Bridell, T. Gloe, J. Duyster, U. Pohl, and H.-Y. Sohn
The Tyrosine Phosphatase, SHP-1, Is a Negative Regulator of Endothelial Superoxide Formation
J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1700 - 1706.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. K. Lund, H. S. Andersen, L. F. Iversen, O. H. Olsen, K. B. Moller, A. K. Pedersen, Y. Ge, D. D. Holsworth, M. J. Newman, F. U. Axe, et al.
Structure-based Design of Selective and Potent Inhibitors of Protein-tyrosine Phosphatase {beta}
J. Biol. Chem., June 4, 2004; 279(23): 24226 - 24235.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Mukhopadhyay, Y. Zhou, and B. P. Rosen
Directed Evolution of a Yeast Arsenate Reductase into a Protein-tyrosine Phosphatase
J. Biol. Chem., June 27, 2003; 278(27): 24476 - 24480.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Ghosh, C. Pal, M. Ray, S. Maitra, L. Mandal, and S. Bandyopadhyay
Dendritic Cell-Based Immunotherapy Combined with Antimony-Based Chemotherapy Cures Established Murine Visceral Leishmaniasis
J. Immunol., June 1, 2003; 170(11): 5625 - 5629.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Nandan, T. Yi, M. Lopez, C. Lai, and N. E. Reiner
Leishmania EF-1alpha Activates the Src Homology 2 Domain Containing Tyrosine Phosphatase SHP-1 Leading to Macrophage Deactivation
J. Biol. Chem., December 13, 2002; 277(51): 50190 - 50197.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. K. Pathak, D. Dhawan, D. J. Lindner, E. C. Borden, C. Farver, and T. Yi
Pentamidine Is an Inhibitor of PRL Phosphatases with Anticancer Activity
Mol. Cancer Ther., December 1, 2002; 1(14): 1255 - 1264.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Yi, M. K. Pathak, D. J. Lindner, M. E. Ketterer, C. Farver, and E. C. Borden
Anticancer Activity of Sodium Stibogluconate in Synergy with IFNs
J. Immunol., November 15, 2002; 169(10): 5978 - 5985.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. R. Engwerda, M. Ato, S. E. J. Cotterell, T. L. Mynott, A. Tschannerl, P. M. A. Gorak-Stolinska, and P. M. Kaye
A Role for Tumor Necrosis Factor-{alpha} in Remodeling the Splenic Marginal Zone during Leishmania donovani Infection
Am. J. Pathol., August 1, 2002; 161(2): 429 - 437.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.